Dyadic International Inc. (DYAI)
DYAI trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.4253
+1.00% on the day
Market cap
$17.0M
Nano cap
Revenue · 2025
$3.1M
-11.6% on 2024
Net income · 2025
-$7.4M
-238.3% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | DYAI on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001213809 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $3.1M |
| Net income | -$7.4M |
| Operating income | -$7.2M |
| Net margin | -238.3% |
| Operating margin | -232.8% |
| Revenue growth | -11.6% |
| Cash | $4.6M |
| Total assets | $9.9M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 5.5× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-09-18 |
| Latest annual report | 10-K/A | 2026-04-30 |
| Latest quarterly / interim | 10-Q | 2026-08-12 |
| Latest current report | 8-K | 2026-09-25 |
| Latest proxy | DEFA14A | 2026-06-18 |
Source: SEC EDGAR submissions feed, 539 recent filings. All filings on EDGAR.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| JSPR | Jasper Therapeutics Inc. | $0.4956 | -10.70% | $16.5M |
| BCDA | BioCardia Inc. | $0.9903 | -2.91% | $15.0M |
| ATYR | aTyr Pharma Inc. | $0.2011 | -6.38% | $19.7M |
| TCRX | TScan Therapeutics Inc. | $0.2167 | -8.91% | $13.8M |
| ESLA | Estrella Immunopharma Inc. | $0.3140 | -4.44% | $13.7M |
| PLUR | Pluri Inc. | $0.9400 | -3.08% | $11.9M |
| PASG | Passage Bio Inc. | $3.64 | -20.00% | $11.7M |
| EVAX | Evaxion A/S American Depositary Share | $2.76 | -8.00% | $24.9M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier